The active ingredient of Yamadin®20 and Yamadin®40 tablet is Famotidine. Famotidine is a novel, highly specific and potent competitive H2- receptor antagonist. It has a rapid onset and prolonged duration of action. Famotidine reduces the acid and pepsin content, as well as the volume of basal, nocturnal and stimulated gastric secretion. Yamadin® tablet is indicated in short term treatment of active duodenal ulcer and benign gastric ulcer, maintenance therapy for prevention of relapses of duodenal ulceration, gastro-oesophageal reflux disease and Zollinger-Ellison Syndrome.

  • Effective against gastric acid disorders
  • Well tolerated by the patients
  • Safe in long term use

Yamadin Prescribing Information